Maria I. Glushkova
Research Subjects
Research Interests
Maria I. Glushkova has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Yulia Yu. Chebotareva
Estelab Clinic LLC; Russian Medical Academy of Continuous Professional Education
4 shared publications - Ekaterina G. Privalova
Estelab Clinic LLC
3 shared publications - E.I. Gubanova
Medical Institute of Continuing Education, Russian Biotechnological University (ROSBIOTECH), Moscow, Russia
2 shared publications - Andrey A. Martynov
Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation
1 shared publication - Anna V. Vlasova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - E.I. Arhangelskaya
Estelab Clinic LLC
1 shared publication
Latest Publications
- 28 August 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (4)
High safety of agarose-based fillers. Personal observation
Restoring lost volume with dermal fillers is a well-established aesthetic technique that utilizes various tissue-injectable materials, such as hyaluronic acid (HA), calcium hydroxyapatite, collagen, poly-L-lactic acid, agarose gel (AG). While HA-based implants remain the market leaders, there is a risk of adverse reactions if enzyme-induced degradation of these gels is necessary. Agarose-based gel is considered safe because it can be easily dissolved and removed from the injection site by administering normal saline and water for injection. Objective. To investigate the effect of solvents (normal saline and water for injection) on the rate of induced degradation of agarose gel in vitro and in vivo. Material and methods. A clinical observation of 5 patients was performed to evaluate the feasibility of controlled dissolution of an agarose-based filler using normal saline and water for injection. Agarose-based gels (at concentrations of 1.5 and 2.5%) were subjected to induced degradation by two solutions: 0.9% sodium chloride and water for injection. The induced degradation process was assessed by studying the physicochemical and rheological properties of the gel in vitro and ultrasound imaging of soft tissues in vivo. Results. Both agents effectively dissolve the AG-based gel. In vitro studies revealed the lowest stability in samples exposed to water for injection as the solvent, indicating significantly faster filler degradation compared to those treated with normal saline. In vivo, water for injection also showed greater dissolution capacity than normal saline. The AG-based filler bolus was completely degraded after a single use of water for injection, which was confirmed by ultrasound imaging. Conclusion. The efficacy and safety of using normal saline and water for injection to induce agarose gel degradation were demonstrated.
- 28 August 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (4)
High safety of agarose-based fillers. Personal observation
Restoring lost volume with dermal fillers is a well-established aesthetic technique that utilizes various tissue-injectable materials, such as hyaluronic acid (HA), calcium hydroxyapatite, collagen, poly-L-lactic acid, agarose gel (AG). While HA-based implants remain the market leaders, there is a risk of adverse reactions if enzyme-induced degradation of these gels is necessary. Agarose-based gel is considered safe because it can be easily dissolved and removed from the injection site by administering normal saline and water for injection. Objective. To investigate the effect of solvents (normal saline and water for injection) on the rate of induced degradation of agarose gel in vitro and in vivo. Material and methods. A clinical observation of 5 patients was performed to evaluate the feasibility of controlled dissolution of an agarose-based filler using normal saline and water for injection. Agarose-based gels (at concentrations of 1.5 and 2.5%) were subjected to induced degradation by two solutions: 0.9% sodium chloride and water for injection. The induced degradation process was assessed by studying the physicochemical and rheological properties of the gel in vitro and ultrasound imaging of soft tissues in vivo. Results. Both agents effectively dissolve the AG-based gel. In vitro studies revealed the lowest stability in samples exposed to water for injection as the solvent, indicating significantly faster filler degradation compared to those treated with normal saline. In vivo, water for injection also showed greater dissolution capacity than normal saline. The AG-based filler bolus was completely degraded after a single use of water for injection, which was confirmed by ultrasound imaging. Conclusion. The efficacy and safety of using normal saline and water for injection to induce agarose gel degradation were demonstrated.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (3) , 497-506
Ultrasound and morphological characteristics of the lower face tissue changes in the submandibular and submental regions after the use of cryolipolysis and its combination with microfocused ultrasound
Background. Cryolipolysis (CL) is a non-invasive technique that provides selective reduction of adipocyte number. At the same time, understanding of the specific changes in the skin and subcutaneous adipose tissue when using combined protocols, for example with microfocused ultrasound (MFUS), is insufficient. Therefore, there is a need for a more detailed study of structural changes in tissues with various therapeutic approaches. Objective. To evaluate morphological and ultrasound changes in the skin in the submental and submandibular regions after the use of CL and its combination with MFUS. Material and methods. Ultrasound was performed before hardware methods (D01), after 3, 6 and 12 months (M03, M06 and M12, respectively) in 30 patients (15 patients from each group). Histological examination was done in 6 patients (3 patients from each group). In the 1st group (CL), a repeat biopsy was taken 3 months after the CL procedure (M03). In the 2nd group (CL+MFUS with visualization), re-sampling was performed twice: 3 months after CL (M03) and 3 months after MFUS with visualization (M06). Results. In the CL+MFUS-V group, a tendency towards increased dermal thickness and a decrease in subcutaneous fat thickness was observed. In the CL group, similar changes were recorded on M03 while the impact was the same, but later the severity of changes decreased. According to morphometric analysis, both methods demonstrate comparable effectiveness, while the combined impact is characterized by more pronounced dynamics of changes. Conclusion. The obtained results indicate the potential of a combined approach for correcting changes in the lower face.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (3) , 497-506
Ultrasound and morphological characteristics of the lower face tissue changes in the submandibular and submental regions after the use of cryolipolysis and its combination with microfocused ultrasound
Background. Cryolipolysis (CL) is a non-invasive technique that provides selective reduction of adipocyte number. At the same time, understanding of the specific changes in the skin and subcutaneous adipose tissue when using combined protocols, for example with microfocused ultrasound (MFUS), is insufficient. Therefore, there is a need for a more detailed study of structural changes in tissues with various therapeutic approaches. Objective. To evaluate morphological and ultrasound changes in the skin in the submental and submandibular regions after the use of CL and its combination with MFUS. Material and methods. Ultrasound was performed before hardware methods (D01), after 3, 6 and 12 months (M03, M06 and M12, respectively) in 30 patients (15 patients from each group). Histological examination was done in 6 patients (3 patients from each group). In the 1st group (CL), a repeat biopsy was taken 3 months after the CL procedure (M03). In the 2nd group (CL+MFUS with visualization), re-sampling was performed twice: 3 months after CL (M03) and 3 months after MFUS with visualization (M06). Results. In the CL+MFUS-V group, a tendency towards increased dermal thickness and a decrease in subcutaneous fat thickness was observed. In the CL group, similar changes were recorded on M03 while the impact was the same, but later the severity of changes decreased. According to morphometric analysis, both methods demonstrate comparable effectiveness, while the combined impact is characterized by more pronounced dynamics of changes. Conclusion. The obtained results indicate the potential of a combined approach for correcting changes in the lower face.
- 22 June 2026
- Published by Russian Biotechnological University (ROSBIOTECH) in Bulletin of the Medical Institute of Continuing Education
- Vol. 6 (2)
EFFICACY OF CRYOLIPOLYSIS AND ITS COMBINATION WITH MICROFOCUSED ULTRASOUND IN THE CORRECTION OF AGE-RELATED CHANGES IN THE LOWER THIRD OF THE FACE AND SUBMANDIBULAR AREA: A PROSPECTIVE COMPARATIVE COHORT STUDY
Background. Cryolipolysis (CL) and microfocused ultrasound with visualization (MFU-V) are effective and safe methods for the correction of excessive subcutaneous fat (SCF) in the submental and submandibular areas. However, data on the effectiveness of their combined use in the lower third of the face remain limited. Purpose. To evaluate the efficacy of cryolipolysis as monotherapy and in combination with MFU-V for improving skin quality and reducing subcutaneous fat volume. Materials and methods. A prospective multicenter comparative non-randomized cohort study included 108 patients aged 35–65 years. Participants were divided into two groups: group 1 (CL, n=54) received cryolipolysis only; group 2 (CL+MFU-V, n=54) received cryolipolysis followed by MFU-V after 3 months. Treatment efficacy was assessed using GAIS, SCF severity scales, caliper measurements, and the total aging index (TAI). Results. Both groups demonstrated a statistically significant reduction in SCF severity and skinfold thickness. The combined protocol was associated with more pronounced improvements in several parameters. The most notable differences between the groups were observed at 6 months and persisted up to 12 months. Conclusion. The combined use of cryolipolysis and MFU-V provides a more pronounced and sustained clinical effect compared to monotherapy.
- 22 June 2026
- Published by Russian Biotechnological University (ROSBIOTECH) in Bulletin of the Medical Institute of Continuing Education
- Vol. 6 (2)
EFFICACY OF CRYOLIPOLYSIS AND ITS COMBINATION WITH MICROFOCUSED ULTRASOUND IN THE CORRECTION OF AGE-RELATED CHANGES IN THE LOWER THIRD OF THE FACE AND SUBMANDIBULAR AREA: A PROSPECTIVE COMPARATIVE COHORT STUDY
Background. Cryolipolysis (CL) and microfocused ultrasound with visualization (MFU-V) are effective and safe methods for the correction of excessive subcutaneous fat (SCF) in the submental and submandibular areas. However, data on the effectiveness of their combined use in the lower third of the face remain limited. Purpose. To evaluate the efficacy of cryolipolysis as monotherapy and in combination with MFU-V for improving skin quality and reducing subcutaneous fat volume. Materials and methods. A prospective multicenter comparative non-randomized cohort study included 108 patients aged 35–65 years. Participants were divided into two groups: group 1 (CL, n=54) received cryolipolysis only; group 2 (CL+MFU-V, n=54) received cryolipolysis followed by MFU-V after 3 months. Treatment efficacy was assessed using GAIS, SCF severity scales, caliper measurements, and the total aging index (TAI). Results. Both groups demonstrated a statistically significant reduction in SCF severity and skinfold thickness. The combined protocol was associated with more pronounced improvements in several parameters. The most notable differences between the groups were observed at 6 months and persisted up to 12 months. Conclusion. The combined use of cryolipolysis and MFU-V provides a more pronounced and sustained clinical effect compared to monotherapy.
- 31 May 2026
- Published by ECO-Vector LLC (Publications) in Russian Journal of Skin and Venereal Diseases
- Vol. 29 (3) , 375-389
Photodynamic therapy and photobiomodulation in the treatment of erythematotelangiectatic and papulopustular rosacea subtypes: a pilot, open-label, non-randomized, controlled prospective study
BACKGROUND: Data on the clinical efficacy of combined photodynamic therapy (PDT) and photobiomodulation (PBM) in rosacea are limited to a small number of studies, mostly based on subjective assessment methods. Only a few studies include objective instrumental parameters reflecting skin microcirculation and standardized clinical scales. AIM: To evaluate the clinically and instrumentally confirmed efficacy of combined PDT and PBM together with specialized home skincare, including topical ivermectin cream, in patients with erythematotelangiectatic and papulopustular subtypes of rosacea. METHODS: This pilot study, with within-group comparison of pre- and post-treatment parameters, included 9 patients aged 27–44 years with rosacea, facial erythema, telangiectasia, and papulopustular lesions, who were divided into 3 groups of 3 patients each depending on the clinical subtype of rosacea and the treatment regimen (PDT+PBM, 6 sessions at 7-day intervals) combined with a home skincare line. Assessment methods included photographic documentation, ultrasound examination with Doppler modes to assess vascularization, and the GAIS (Global Aesthetic Improvement Scale), DLQI (Dermatology Life Quality Index), IGA (Investigator Global Assessment), and RDAS (Rosacea Diagnostic Assessment Scale). RESULTS: Improvement in clinical parameters was observed in all treatment groups, confirmed by objective and subjective assessment methods. Specifically, lower scores after treatment compared with baseline indicated a transition from moderate erythema to very mild erythema on the IGA (p 0.001), a reduction in overall rosacea symptom severity on the RDAS (p 0.001), and a shift from moderate to minimal impact of the disease on quality of life on the DLQI (p 0.001). According to 3D Antera 3D imaging, a reduction in the vascular component and changes in vascular pattern homogeneity were observed in all three groups, as well as statistically significant improvement in the microvascular network parameters. Group 3 showed the greatest improvement, with a 52.4% reduction in the vascularization index (p=0.005), a 35.2% decrease in vessel diameter (p=0.003), and a 28.7% reduction in vessel depth (p=0.023). In addition, patients reported a subjective reduction in facial discomfort. CONCLUSION: These data indicate the potential efficacy of PDT and PBM in combination with home skincare. The combined approach using ivermectin cream in the treatment of various rosacea subtypes shows the most pronounced therapeutic outcomes.
- 31 May 2026
- Published by ECO-Vector LLC (Publications) in Russian Journal of Skin and Venereal Diseases
- Vol. 29 (3) , 375-389
Photodynamic therapy and photobiomodulation in the treatment of erythematotelangiectatic and papulopustular rosacea subtypes: a pilot, open-label, non-randomized, controlled prospective study
BACKGROUND: Data on the clinical efficacy of combined photodynamic therapy (PDT) and photobiomodulation (PBM) in rosacea are limited to a small number of studies, mostly based on subjective assessment methods. Only a few studies include objective instrumental parameters reflecting skin microcirculation and standardized clinical scales. AIM: To evaluate the clinically and instrumentally confirmed efficacy of combined PDT and PBM together with specialized home skincare, including topical ivermectin cream, in patients with erythematotelangiectatic and papulopustular subtypes of rosacea. METHODS: This pilot study, with within-group comparison of pre- and post-treatment parameters, included 9 patients aged 27–44 years with rosacea, facial erythema, telangiectasia, and papulopustular lesions, who were divided into 3 groups of 3 patients each depending on the clinical subtype of rosacea and the treatment regimen (PDT+PBM, 6 sessions at 7-day intervals) combined with a home skincare line. Assessment methods included photographic documentation, ultrasound examination with Doppler modes to assess vascularization, and the GAIS (Global Aesthetic Improvement Scale), DLQI (Dermatology Life Quality Index), IGA (Investigator Global Assessment), and RDAS (Rosacea Diagnostic Assessment Scale). RESULTS: Improvement in clinical parameters was observed in all treatment groups, confirmed by objective and subjective assessment methods. Specifically, lower scores after treatment compared with baseline indicated a transition from moderate erythema to very mild erythema on the IGA (p 0.001), a reduction in overall rosacea symptom severity on the RDAS (p 0.001), and a shift from moderate to minimal impact of the disease on quality of life on the DLQI (p 0.001). According to 3D Antera 3D imaging, a reduction in the vascular component and changes in vascular pattern homogeneity were observed in all three groups, as well as statistically significant improvement in the microvascular network parameters. Group 3 showed the greatest improvement, with a 52.4% reduction in the vascularization index (p=0.005), a 35.2% decrease in vessel diameter (p=0.003), and a 28.7% reduction in vessel depth (p=0.023). In addition, patients reported a subjective reduction in facial discomfort. CONCLUSION: These data indicate the potential efficacy of PDT and PBM in combination with home skincare. The combined approach using ivermectin cream in the treatment of various rosacea subtypes shows the most pronounced therapeutic outcomes.